Sign in
GBS Stock Price, Chart, Stats & News
GBS Inc.
Save
GBS Inc. (GBS) does not currently pay a dividend.
433,577
Market cap
–
Current P/E
–
Forward P/E
GBS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 46.21% |
Operating margin | -315.25% |
Pretax margin | -315.36% |
Net margin | -315.36% |
Effective tax rate | – |
ROA | -63.98% |
ROE | -197.94% |
D/E | 0.17x |
Interest coverage ratio | 414.40x |
GBS valuation
P/E | – |
P/S | 0.12x |
P/B | 0.04x |
P/CF | -0.05x |
P/FCF | -0.04x |
P/OCF | -0.05x |
PEG | 0.00x |
EV multiple | 0.06x |
About
Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids.
Similar securities
Based on sector and market capitalization
Report issue